Understanding How an Anticancer Drug Works Can Pave the Way for Personalized Therapy
PHILADELPHIA (February 16, 2016) – Fox Chase Cancer Center – Temple Health researchers have identified a way forward for personalized cancer treatments for a wide range of cancers by understanding how to stimulate the activity of a potent anticancer protein called TRAIL. ONC201 not only stimulates TRAIL, but also the death receptor for TRAIL on tumor cells.